Ferroptosis stress elicits PD‐L1 expression in head and neck cancer cells and modulates tumor microenvironments to an immune‐active state, highlighting the potential of priming tumors with ferroptosis inducers to potentiate the antitumor efficacy of immunotherapy. The gene discussed is CD274; the disease is neoplasm.